|
The OECD report on Counterfeiting and Piracy of Pharmaceuticals will be published in 2008. Counterfeiting and piracy of pharmaceutical products is an opportunistic crime endangering the lives of patients and consumers. This report examines the nature of counterfeiting and piracy activities from the health and safety, public security, business and intellectual property perspective.
The report also examines the diverse definitions of counterfeit pharmaceuticals, the nature and scope of counterfeiting activities and the modes of operation. It assesses trends and magnitude, evaluates the impacts on patients/consumers, especially public health implications, on the private sector and on governments, and analyses measures employed for combating counterfeiting of pharmaceuticals (including, technology, legislative and regulatory mechanisms, education and risk communication, enforcement, securing of distribution/supply chain, and international cooperation).
|
